000182075 001__ 182075
000182075 005__ 20241230121009.0
000182075 0247_ $$2doi$$a10.1007/s00520-022-07397-5
000182075 0247_ $$2pmid$$apmid:36227505
000182075 0247_ $$2ISSN$$a0941-4355
000182075 0247_ $$2ISSN$$a1433-7339
000182075 0247_ $$2altmetric$$aaltmetric:139593718
000182075 037__ $$aDKFZ-2022-02403
000182075 041__ $$aEnglish
000182075 082__ $$a610
000182075 1001_ $$0P:(DE-He78)4efdb2a34deea12413d61f7ddc9eba99$$aMilzer, Marlena$$b0$$eFirst author$$udkfz
000182075 245__ $$aThe cancer patients' perspective on feasibility of using a fatigue diary and the benefits on self-management: results from a longitudinal study.
000182075 260__ $$aNew York,NY$$bSpringer$$c2022
000182075 3367_ $$2DRIVER$$aarticle
000182075 3367_ $$2DataCite$$aOutput Types/Journal article
000182075 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1670234770_20890
000182075 3367_ $$2BibTeX$$aARTICLE
000182075 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000182075 3367_ $$00$$2EndNote$$aJournal Article
000182075 500__ $$a#EA:C110#LA:C110# / 2022 Dec;30(12):10213-10221
000182075 520__ $$aTo evaluate the patients' perspective on feasibility of using a fatigue diary and its benefits on self-management.This longitudinal study enrolled 50 cancer patients in routine care. Following baseline (t0) assessment, patients were asked to complete a 7-day fatigue diary and subsequently obtained written diary evaluation. Feasibility, benefits, and fatigue-related attitudes were assessed via self-report 1 (t1) and 4 months (t2) after distributing the diary. Data were analyzed descriptively and using Wilcoxon signed-rank tests.Most patients (94%) completed the diary for 7 days and rated feasibility as high. After diary completion and receiving the evaluation, fewer patients felt helpless in the face of fatigue (t1: 21% vs. t0: 53%). Additionally, more patients addressed fatigue with their general practitioner (t2: 49% vs. t0: 36%) and pro-actively searched for information and help (t2: 59% vs. t0: 38%). The diary enabled a majority of patients to be aware of their fatigue patterns, to plan daily routines accordingly and to take adequate actions against fatigue.The study showed that symptom monitoring via a fatigue diary was considered feasible and enhanced self-management in cancer patients. Thus, fatigue diaries might be a useful measure contributing to an improved fatigue management. The results reinforce guideline recommendations for routine application of fatigue diaries in clinical care. Healthcare professionals should encourage patients to fatigue diary use and provide individually tailored counseling based on diary entries.
000182075 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000182075 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000182075 650_7 $$2Other$$aCancer-related fatigue
000182075 650_7 $$2Other$$aSelf-management
000182075 650_7 $$2Other$$aSelf-monitoring
000182075 650_7 $$2Other$$aSupportive care
000182075 650_7 $$2Other$$aSymptom diary
000182075 7001_ $$0P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aSteindorf, Karen$$b1$$udkfz
000182075 7001_ $$0P:(DE-He78)2fea027fd35806305cdce65acd02d607$$aReinke, Paul$$b2
000182075 7001_ $$0P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac$$aSchmidt, Martina$$b3$$eLast author$$udkfz
000182075 773__ $$0PERI:(DE-600)1463166-0$$a10.1007/s00520-022-07397-5$$n12$$p10213-10221$$tSupportive care in cancer$$v30$$x0941-4355$$y2022
000182075 8767_ $$8V52536$$92023-12-01$$d2024-12-30$$eHybrid-OA$$jZahlung erfolgt
000182075 909CO $$ooai:inrepo02.dkfz.de:182075$$pVDB$$pOpenAPC$$popenCost
000182075 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4efdb2a34deea12413d61f7ddc9eba99$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000182075 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000182075 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2fea027fd35806305cdce65acd02d607$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000182075 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000182075 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000182075 9141_ $$y2022
000182075 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2021-01-26$$wger
000182075 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-26
000182075 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-26
000182075 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-15
000182075 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-15
000182075 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-15
000182075 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-15
000182075 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-15
000182075 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bSUPPORT CARE CANCER : 2021$$d2022-11-15
000182075 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-15
000182075 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-15
000182075 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2022-11-15
000182075 915pc $$0PC:(DE-HGF)0000$$2APC$$aAPC keys set
000182075 915pc $$0PC:(DE-HGF)0001$$2APC$$aLocal Funding
000182075 9202_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x0
000182075 9201_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x0
000182075 9200_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x0
000182075 980__ $$ajournal
000182075 980__ $$aVDB
000182075 980__ $$aI:(DE-He78)C110-20160331
000182075 980__ $$aUNRESTRICTED
000182075 980__ $$aAPC